September 2007

Seating is limited to 65 participants.

Due to PhRMA Guidelines, persons who are not a healthcare provider are not eligible to attend this event. Persons not a member of the Capital Area Pharmacy Association must pay a $30 registration fee for the event.

Update on Parkinson's Disease:
Treatment in Early and Moderate-to-Advance Disease States

Speaker
 Thomas Hill, MD
Sponsor

TEVA Neuroscience, Sherri Brooks

Date
 Thursday, September 27, 2007
Location
 Cool River Cafe
Address

4001 Parmer Lane -- Austin, Texas 78727

Phone
 (512) 835-0010
Agenda

6:30 PM, Networking and Registration
7:00 PM, Dinner
7:45 PM, Program
9:15 PM, Question and Answer
9:30 PM, Adjourn

CE Info.
 Texas Pharmacy Association (154) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned ACPE number 154-999-07-404-L01 and is accredited for 1.5 Contact Hours (0.15 CEUs).

ACPE Statement of Credit will be mailed within 30 days to all registrants who sign the attendance list, complete an evaluation, and meet all other stated completion criteria.

Pharmacist Learning Objectives:

  1. List the cardinal symptoms of Parkinson's Disease and some of the features of Parkinson's syndrome
  2. List the medications used for Parkinson's Disease and their roles in the management of Parkinson's Disease
  3. Discuss the management of Parkinson's Disease considering the functional status of the patient
  4. List some of the non-dopaminergic symptoms and the drugs used in the treatment of these issues

Pharmacy Technician Learning Objectives:

  1. Be able to list the symptoms of Parkinson’s Disease and some of the features of Parkinson’s syndrome.
  2. Be able to list the medications used for Parkinson’s Disease and their roles in the management of Parkinson’s Disease.
  3. Be able to briefly discuss the pharmacist’s role in management of Parkinson’s Disease
  4. Identify and define the term non-dopaminergic
  5. List some of drugs used in the treatment of non-dopaminergic issues.
RSVP via Evite by September 25, 2007.